The estimated Net Worth of Iii Thomas F Zenty is at least $4.85 Thousand dollars as of 3 April 2019. Iii Zenty owns over 3,025 units of Endologix stock worth over $4,852 and over the last 11 years Iii sold ELGX stock worth over $0.
Iii has made over 4 trades of the Endologix stock since 2016, according to the Form 4 filled with the SEC. Most recently Iii bought 3,025 units of ELGX stock worth $19,995 on 3 April 2019.
The largest trade Iii's ever made was buying 5,000 units of Endologix stock on 22 May 2017 worth over $22,200. On average, Iii trades about 1,169 units every 72 days since 2013. As of 3 April 2019 Iii still owns at least 22,053 units of Endologix stock.
You can see the complete history of Iii Zenty stock trades at the bottom of the page.
Iii's mailing address filed with the SEC is 2, Musick, Irvine Spectrum, Irvine, Orange, California, 92618, United States of America.
Over the last 22 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott, and Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: